332
Views
2
CrossRef citations to date
0
Altmetric
Review Articles

Sarcoid Uveitis in Children

, FRANZCO, PhDORCID Icon & , MD, PhD
Pages 1965-1970 | Received 12 Aug 2023, Accepted 07 Nov 2023, Published online: 20 Nov 2023

References

  • Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Muller-Quernheim JS. Sarcoidosis. Nat Rev Dis Primers. 2019;5(1):45. doi:10.1038/s41572-019-0096-x.
  • Jones N, Mochizuki M. Sarcoidosis: epidemiology and clinical features. Ocul Immunol Inflamm. 2010;18(2):72–79. doi:10.3109/09273941003710598.
  • Jamilloux Y, Kodjikian L, Broussolle C, Seve P. Sarcoidosis and uveitis. Autoimmun Rev. 2014;13(8):840–849. doi:10.1016/j.autrev.2014.04.001.
  • Maleki A, Anesi SD, Look-Why S, Manhapra A, Foster CS. Pediatric uveitis: a comprehensive review. Surv Ophthalmol. 2022;67(2):510–529. doi:10.1016/j.survophthal.2021.06.006.
  • Fayez Goubran W, El Gemai E, et al. Pattern of childhood uveitis in Egypt. Ocul Immunol Inflamm. 2019;27(6):883–889. doi:10.1080/09273948.2018.1502325.
  • Mousa R, Tawfeeq Mahdi M, et al. Etiology of pediatric uveitis in a tertiary pediatric eye hospital in Egypt. Ocul Immunol Inflamm. In press. doi:10.1080/09273948.2022.2117201.
  • Siiskonen M, Hirn I, Pesala R, Hautala T, Ohtonen P, Hautala N. Prevalence, incidence and epidemiology of childhood uveitis. Acta Ophthalmol. 2021;99(2):e160–e163. doi:10.1111/aos.14535.
  • Morelle G, Gueudry J, Uettwiller F, et al. Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort. RMD Open. 2019;5(2):e000933. doi:10.1136/rmdopen-2019-000933.
  • Markomichelakis NN, Aissopou EK, Chatzistefanou KI. Pediatric non-infectious uveitis: long-term outcomes and complications. Ocul Immunol Inflamm. In press. doi:10.1080/09273948.2022.2162422.
  • Kumar P, Gupta A, Bansal R, et al. Chronic uveitis in children. Indian J Pediatr. 2022;89(4):358–363. doi:10.1007/s12098-021-03884-5.
  • Waduthantri S, Chee SP. Pediatric uveitis and scleritis in a multi-ethnic Asian population. Ocul Immunol Inflamm. 2021;29(7–8):1304–1311. doi:10.1080/09273948.2020.1766083.
  • Shin Y, Kang JM, Lee J, Lee CS, Lee SC, Ahn JG. Epidemiology of pediatric uveitis and associated systemic diseases. Pediatr Rheumatol Online J. 2021;19(1):48. doi:10.1186/s12969-021-00516-2.
  • Hoogewoud F, Cohen J, Rossi D, et al. Epidemiology of childhood uveitis in a tertiary care center: a 20-year study. Klin Monbl Augenheilkd. 2021;238(4):469–473. doi:10.1055/a-1384-0351.
  • Seepongphun U, Sittivarakul W, Dangboon W, Chotipanvithayakul R. The pattern of uveitis in a pediatric population at a tertiary center in Thailand. Ocul Immunol Inflamm. 2023;31(1):56–64. doi:10.1080/09273948.2021.1980814.
  • Eser-Ozturk H, Sullu Y. Pediatric uveitis in a referral center in north part of Turkey. Ocul Immunol Inflamm. 2021;29(7–8):1299–1303. doi:10.1080/09273948.2020.1758158.
  • Esen E, Sizmaz S, Balci S, Ekinci RMK, Demircan N. Clinical features of childhood uveitis at a tertiary referral center in Southern Turkey. Int Ophthalmol. 2021;41(6):2073–2081. doi:10.1007/s10792-021-01764-7.
  • Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116(8):1544–1551.e1. doi:10.1016/j.ophtha.2009.05.002.
  • Ferrara M, Eggenschwiler L, Stephenson A, et al. The challenge of pediatric uveitis: tertiary referral center experience in the United States. Ocul Immunol Inflamm. 2019;27(3):410–417. doi:10.1080/09273948.2017.1420202.
  • Lindsley CB, Petty RE. Overview and report on international registry of sarcoid arthritis in childhood. Curr Rheumatol Rep. 2000;2(4):343–348. doi:10.1007/s11926-000-0073-z.
  • Hoffmann AL, Milman N, Byg KE. Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr. 2004;93(1):30–36. doi:10.1111/j.1651-2227.2004.tb00670.x.
  • Choi DE, Birnbaum AD, Oh F, Tessler HH, Goldstein DA. Pediatric uveitis secondary to probable, presumed, and biopsy-proven sarcoidosis. J Pediatr Ophthalmol Strabismus. 2011;48(3):157–162. doi:10.3928/01913913-20100518-01.
  • Hoover DL, Khan JA, Giangiacomo J. Pediatric ocular sarcoidosis. Surv Ophthalmol. 1986;30(4):215–228. doi:10.1016/0039-6257(86)90118-9.
  • Kanazawa N, Okafuji I, Kambe N, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood. 2005;105(3):1195–1197. doi:10.1182/blood-2004-07-2972.
  • Ohto U. Activation and regulation mechanisms of NOD-like receptors based on structural biology. Front Immunol. 2022;13:953530. doi:10.3389/fimmu.2022.953530.
  • Caso F, Costa L, Rigante D, et al. Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev. 2014;13(12):1220–1229. doi:10.1016/j.autrev.2014.08.010.
  • Napier RJ, Lee EJ, Davey MP, et al. T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis. Nat Commun. 2020;11(1):5406. doi:10.1038/s41467-020-18961-0.
  • Sarens IL, Casteels I, Anton J, et al. Blau syndrome-associated uveitis: preliminary results from an international prospective interventional case series. Am J Ophthalmol. 2018;187:158–166. doi:10.1016/j.ajo.2017.08.017.
  • Takeuchi Y, Shigemura T, Kobayashi N, et al. Early diagnosis of early-onset sarcoidosis: a case report with functional analysis and review of the literature. Clin Rheumatol. 2017;36(5):1189–1196. doi:10.1007/s10067-017-3544-6.
  • Okafuji I, Nishikomori R, Kanazawa N, et al. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 2009;60(1):242–250. doi:10.1002/art.24134.
  • Matsuda T, Kambe N, Ueki Y, et al. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation. Ann Rheum Dis. 2020;79(11):1492–1499. doi:10.1136/annrheumdis-2020-217320.
  • Zhang H, Costabel U, Dai H. The role of diverse immune cells in sarcoidosis. Front Immunol. 2021;12:788502. doi:10.3389/fimmu.2021.788502.
  • Malkova A, Zinchenko Y, Starshinova A, et al. Sarcoidosis: progression to the chronic stage and pathogenic based treatment (narrative review). Front Med (Lausanne). 2022;9:963435. doi:10.3389/fmed.2022.963435.
  • Davoudi S, Navarro-Gomez D, Shen L, et al. NOD2 genetic variants and sarcoidosis-associated uveitis. Am J Ophthalmol Case Rep. 2016;3:39–42. doi:10.1016/j.ajoc.2016.05.005.
  • Ma SP, Rogers SL, Hall AJ, et al. Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis. Am J Ophthalmol. 2019;198:30–36. doi:10.1016/j.ajo.2018.09.013.
  • Herbort CP, Rao NA, Mochizuki M. Members of scientific committee of first international workshop on ocular sarcoidosis. international criteria for the diagnosis of ocular sarcoidosis: results of the first international workshop on ocular sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160–169. doi:10.1080/09273940902818861.
  • Gedalia A, Khan TA, Shetty AK, Dimitriades VR, Espinoza LR. Childhood sarcoidosis: Louisiana experience. Clin Rheumatol. 2016;35(7):1879–1884. doi:10.1007/s10067-015-2870-9.
  • Niederer RL, Ma SP, Wilsher ML, et al. Systemic associations of sarcoid uveitis: correlation with uveitis phenotype and ethnicity. Am J Ophthalmol. 2021;229:169–175. doi:10.1016/j.ajo.2021.03.003.
  • Mochizuki M, Smith JR, Takase H, et al. Revised criteria of international workshop on ocular sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103(10):1418–1422. doi:10.1136/bjophthalmol-2018-313356.
  • Standardization of Uveitis Nomenclature Working Group. Development of classification criteria for the uveitides. Am J Ophthalmol. 2021;228:96–105. doi:10.1016/j.ajo.2021.03.061.
  • Birnbaum AD, Huang W, Sahin O, Tessler HH, Goldstein DA. Ocular sarcoidosis misdiagnosed as primary intraocular lymphoma. Retina. 2010;30(2):310–316. doi:10.1097/iae.0b013e3181b773fc.
  • El Jammal T, Jamilloux Y, Gerfaud-Valentin M, et al. Challenging mimickers in the diagnosis of sarcoidosis: a case study. Diagnostics (Basel). 2021;11(7):1240. doi:10.3390/diagnostics11071240.
  • Sullu Y, Yildiran A, Sullu Y, Helek D, Ozkaya O. Sarcoid uveitis simulating birdshot chorioretinopathy in a child. Retin Cases Brief Rep. 2012;6(1):7–10. doi:10.1097/ICB.0b013e3181f7455d.
  • Eser-Ozturk H, Izci Duran T, Aydog O, Sullu Y. Sarcoid-like uveitis with or without tubulointerstitial nephritis during COVID-19. Ocul Immunol Inflamm. 2023;31(3):483–490. doi:10.1080/09273948.2022.2032195.
  • Alhajri M, Aljumaah S, Aleyouni Y, Al-Qahtani F, Alhazzaa S, Al-Mayouf SM. Granulomatous disease in a child treated with etanercept. Int J Rheum Dis. 2013;16(4):472–474. doi:10.1111/1756-185X.12078.
  • Hashkes PJ, Shajrawi I. Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatol. 2003;21:645–646.
  • Kluger N. Tattoo-associated uveitis with or without systemic sarcoidosis: a comparative review of the literature. J Eur Acad Dermatol Venereol. 2018;32(11):1852–1861. doi:10.1111/jdv.15070.
  • Ostheimer TA, Burkholder BM, Leung TG, Butler NJ, Dunn JP, Thorne JE. Tattoo-associated uveitis. Am J Ophthalmol. 2014;158(3):637–643.e1. doi:10.1016/j.ajo.2014.05.019.
  • Takase H, Acharya NR, Babu K, et al. Recommendations for the management of ocular sarcoidosis from the international workshop on ocular sarcoidosis. Br J Ophthalmol. 2021;105(11):1515–1519. doi:10.1136/bjophthalmol-2020-317354.
  • Angeles-Han ST, Lo MS, Henderson LA, et al. Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis. Arthritis Care Res (Hoboken). 2019;71(4):482–491. doi:10.1002/acr.23610.
  • Smith JR, Matthews JM, Conrad D, et al. Recommendations for the management of childhood juvenile idiopathic arthritis-type chronic anterior uveitis. Clin Exp Ophthalmol. 2021;49(1):38–45. doi:10.1111/ceo.13856.
  • Constantin T, Foeldvari I, Anton J, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis. 2018;77(8):1107–1117. doi:10.1136/annrheumdis-2018-213131.
  • Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology. 2010;117(7):1436–1441. doi:10.1016/j.ophtha.2009.12.003.
  • Gunathilaka PK, Mukherjee A, Jat KR, Lodha R, Kabra SK. Clinical profile and outcome of pediatric sarcoidosis. Indian Pediatr. 2019;56(1):37–40. doi:10.1007/s13312-019-1464-z.
  • Ramanan AV, Dick AD, Beresford MW. Adalimumab for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;377(8):789–790. doi:10.1056/NEJMc1708646.
  • Sardar E, Dusser P, Rousseau A, Bodaghi B, Labetoulle M, Kone-Paut I. Retrospective study evaluating treatment decisions and outcomes of childhood uveitis not associated with juvenile idiopathic arthritis. J Pediatr. 2017;186:131–137.e1. doi:10.1016/j.jpeds.2017.03.052.
  • Bazewicz M, Makhoul D, Goffin L, et al. Clinical utility of (18)F-FDG PET/CT in the work-up of children with uveitis. Ocul Immunol Inflamm. 2023;31(1):77–86. doi:10.1080/09273948.2021.1985522.
  • Cavalcanti A, Terreri MT, Matos TC, Hilario MO. Sarcoidosis in childhood: report of three cases. Clin Exp Rheumatol. 2010;28:586.
  • Koay SY, Johnson M, Xing W, et al. Childhood uveitis not associated with juvenile idiopathic arthritis: a national survey of incidence, management and visual outcomes. Eye (Lond). 2021;35(9):2573–2578. doi:10.1038/s41433-020-01267-2.
  • Milman N, Svendsen CB, Hoffmann AL. Health-related quality of life in adult survivors of childhood sarcoidosis. Respir Med. 2009;103(6):913–918. doi:10.1016/j.rmed.2008.12.007.
  • Chauveau S, Jeny F, Montagne ME, et al. Child-adult transition in sarcoidosis: a series of 52 patients. J Clin Med. 2020;9(7):2097. doi:10.3390/jcm9072097.